The Glutethimide Market was valued at US$ 235 Mn. in 2021. The global Glutethimide Market size is expected to grow at a CAGR of 6 % through the forecast period.
Glutethimide Market Overview:Glutethimide is a sedative-hypnotic that is a safe alternative to barbiturates for the treatment of insomnia. It is mainly used to make patients feel drowsy and to help them calm down. Glutethimide is lipophilic and highly concentrated in adipose tissue and the brain. It is an alternative to tranquilizers. It undergoes extensive metabolism in the liver with unconjugated and conjugated metabolites excreted by the kidneys. Glutethimide is an inducer of the CYP2D6 enzyme, and when taken with codeine, it allows the body to convert large amounts of codeine into morphine. The most common brand names for Glutethimide are Ciba, glue, and gofers. It is classified as a Schedule II drug under a psychotropic substance. In addition, Glutethimide is used to prevent jaundice in infants and reduce muscle tremors To know about the Research Methodology :- Request Free Sample Report 2021 is considered as a base year to forecast the market from 2022 to 2027. 2020’s market size is estimated on real numbers and outputs of the key players and major players across the globe. The past five years' trends are considered while forecasting the market through 2027. 2020 is a year of exception and analysis especially with the impact of lockdown by region.
Covid-19 impact:Pharmaceutical and biotech companies and governments around the world are working to respond to the COVID-19 outbreak, from assisting with vaccine development to planning for supply chain challenges and drug response. Currently, about 115 vaccine candidates and 155 molecules are under research and development. In addition, commonly used drugs such as hydroxychloroquine have significantly increased demand for the management of COVID-19. Such high demand for these drugs has presented a huge opportunity for drug manufacturers to manage COVID-19, as many developed countries are facing shortages of these drugs. Therefore, the pharmaceutical and biotechnology sector is expected to experience significant growth in the future due to the demand for COVID-19 vaccines and drugs. This in turn is expected to have a significant impact on the glutethimide market.
Glutethimide Market Dynamics:Glutethimide market drivers: Increase in cardiovascular disease: heart disease remains the number one cause of death in the world heading to 2020 data coronary heart disease accounted for approximately 14.8% of death in us in 2019 causing 365, 744 deaths. Glutethimide also promotes heart health by acting as a precursor to L-Arginine to optimize nitric oxide synthesis. Importantly, Glutethimide reduces many risk factors for cardiovascular diseases, such as hypertension, hyperlipidemia, glucose intolerance, obesity, and diabetes. Hence the increase in the rate of heart disease will lead to an increase in the glutethimide market. Increase in cases of mental illness: the cases related to mental illness are increasing daily. Around 450 million people across the world are facing the issue related to mental illness. Moreover, many mental illnesses are caused due to lack of sleep or a change in the sleep cycle. Hence increase in the cases related to mental illness will lead to an increase in the market growth of the Glutethimide market as glutethimide is used to treat disease-related to mental illness. In addition, spending on health increased; availability of qualified professionals; strengthen R&D activities to improve drug quality; introduce a newly developed drug to the market; and technological developments such as computer technology, aseptic spray drying, and 3D printing for drug production are driving factors for the growth of glutethimide market. The glutethimide market Restraints: Presence of alternative drugs: The presence of alternative drugs such as benzothiazepines for the treatment of disease affects the growth of the glutethimide market. Benzodiazepines are the most widely used class of sedatives. Because of their greater safety and effectiveness, they have largely replaced tranquilizers as the drug of choice in the treatment of anxiety. They also have hypnotic, anticonvulsant, and muscle relaxant activities, but have no analgesic or antipsychotic effects. The side effects of the Drug: the increased side effects of the drug are the major reason for limiting the growth of the drug. The side effects led to overactivity, restlessness, tremor, hyperreflexia, hypotonus, vasomotor instability, incessant crying, and general irritability in infants born to mothers addicted to the Glutethimide drug. Due to the major adverse side effects, the drug was replaced by benzodiazepines which were more effective and safer. Market Trends: A study of 70 patients had completed the treatment of acute glutethimide intoxication a Doriden without the use of Haemodialysis in a Rhode Island hospital. The University of Medicine and Pharmacy in Romania studied the effects of glutethimide on the brains of rats by para-elective treatment with codeine. Guanyin and adenine nucleotides in rat brains were determined by high-performance liquid chromatography.
Glutethimide Market Segment Analysis:Based on Type, the Glutethimide Market is segmented into tablets, injections, capsules, and powder. Among these, the tablet segment holds the highest market share. The formulation of the tablets is manufactured in different dosage forms like 100mg, 250mg, and 500mg. Moreover, the primary route of administration of the Glutethimide drug is the oral route. Hence the tablet segment holds the highest market share. Based on the Application, the Glutethimide Market is segmented into psychiatric use, cardiac use, and prostatic use. Since the drug is categorized as a hypnotic drug and mainly used to calm the patient the drug is mostly used as a psychiatric drug. The application of glutethimide drug as a psychiatric drug holds the maximum market share. Based on the Distribution channel: based on the channel of distribution the market is segmented into retail pharmacies, hospital pharmacies, and online stores. Since the drug is categorized as the SCHEDULE II drug the drugs are mostly purchased in retail stores and only when prescribed by the doctor. Hence the retail stores segment holds the maximum market share.
Glutethimide Market Regional Insights:North America dominated the market in terms of market share and market revenue and will continue to flourish its dominance during the forecast period. This is due to the high prevalence of cases of mental illness diseases and the number of FDA-approved drugs in the region. The Asia Pacific on the other hand is expected to exhibit the highest growth rate during the forecast period due to the focus on various international companies to expand their products in this particular region. The objective of the report is to present a comprehensive analysis of the international Glutethimide Market to the stakeholders in the industry. The past and current status of the industry with the forecast market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that include market leaders, followers, and new entrants. PORTER, PESTEL analysis with the potential impact of micro-economic factors of the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the market to the decision-makers. The reports also help in understanding the Glutethimide Market dynamic, and structure by analyzing the market segments and projecting the Glutethimide Market size. Clear representation of competitive analysis of key players by type, price, financial position, product portfolio, growth strategies, and regional presence in the Glutethimide Market make the report investor’s guide.
Glutethimide Market Scope: Inquire before buying
Global Glutethimide Market Report Coverage Details Base Year: 2021 Forecast Period: 2022-2027 Historical Data: 2017 to 2021 Market Size in 2021: US $ 235 Mn. Forecast Period 2022 to 2027 CAGR: 6% Market Size in 2027: US $ 333.35 Mn. Segments Covered: by Type • Tablets • Injections • Capsules • Powder by Application • Psychiatric use • Cardiac use • prostatic use by Distribution channel • Retail pharmacy • Hospital pharmacy • Online pharmacy stores
Glutethimide Market by Region• North America • Europe • Asia Pacific • South America • Middle East and Africa
Glutethimide Market Key Players• Pfizer Inc • Abbott Laboratories • Mankind Pharma • GSK PLC • Sanofi SA • Novartis • Agilent Technologies • Bristol Mayers Squibb • AstraZeneca • AbbVie Inc • Janssen Global Services • Johnson & Johnson • Astellas • Merck Sharp & Dohme Corp. • UCB SA • ALLERGAN Frequently Asked Questions: 1] What segments are covered in the Global Glutethimide Market report? Ans. The segments covered in the Glutethimide Market report are based on Type, Application, and distribution channel. 2] Which region is expected to hold the highest share in the Global Glutethimide Market? Ans. The North American region is expected to hold the highest share in the Glutethimide Market. 3] What is the market size of the Global Glutethimide Market by 2027? Ans. The market size of the Glutethimide Market by 2027 is expected to reach US$ 333.35 Mn. 4] What is the forecast period for the Global Glutethimide Market? Ans. The forecast period for the Glutethimide Market is 2022-2027. 5] What was the market size of the Global Glutethimide Market in 2021? Ans. The market size of the Glutethimide Market in 2020 was valued at US$ 235 Mn.
1. Global Glutethimide Market Size: Research Methodology 2. Global Glutethimide Market Size: Executive Summary 2.1. Market Overview and Definitions 2.1.1. Introduction to Global Glutethimide Market Size 2.2. Summary 2.2.1. Key Findings 2.2.2. Recommendations for Investors 2.2.3. Recommendations for Market Leaders 2.2.4. Recommendations for New Market Entry 3. Global Glutethimide Market Size: Competitive Analysis 3.1. MMR Competition Matrix 3.1.1. Market Structure by region 3.1.2. Competitive Benchmarking of Key Players 3.2. Consolidation in the Market 3.2.1 M&A by region 3.3. Key Developments by Companies 3.4. Market Drivers 3.5. Market Restraints 3.6. Market Opportunities 3.7. Market Challenges 3.8. Market Dynamics 3.9. PORTERS Five Forces Analysis 3.10. PESTLE 3.11. Regulatory Landscape by region • North America • Europe • Asia Pacific • Middle East and Africa • South America 3.12. COVID-19 Impact 4. Global Glutethimide Market Size Segmentation 4.1. Global Glutethimide Market Size, by Type (2021-2027) • Tablets • Injections • Capsules • Powder 4.2. Global Glutethimide Market Size, by Application (2021-2027) • Psychiatric use • Cardiac use • prostatic use 4.3. Global Glutethimide Market Size, by Distribution channel (2021-2027) • Retail pharmacy • Hospital pharmacy • Online pharmacy stores 5. North America Glutethimide Market (2021-2027) 5.1. North America Glutethimide Market Size, by Type (2021-2027) • Tablets • Injections • Capsules • Powder 5.2. North America Glutethimide Market Size, by Application (2021-2027) • Psychiatric use • Cardiac use • prostatic use 5.3. North America Glutethimide Market Size, by Distribution channel (2021-2027) • Retail pharmacy • Hospital pharmacy • Online pharmacy stores 5.4. North America Glutethimide Market, by Country (2021-2027) • United States • Canada • Mexico 6. Europe Glutethimide Market (2021-2027) 6.1. Europe Glutethimide Market, by Type (2021-2027) 6.2. Europe Glutethimide Market, by Application (2021-2027) 6.3. Europe Glutethimide Market, by Distribution channel (2021-2027) 6.4. Europe Glutethimide Market, by Country (2021-2027) • UK • France • Germany • Italy • Spain • Sweden • Austria • Rest Of Europe 7. Asia Pacific Glutethimide Market (2021-2027) 7.1. Asia Pacific Glutethimide Market, by Type (2021-2027) 7.2. Asia Pacific Glutethimide Market, by Application (2021-2027) 7.3. Asia Pacific Glutethimide Market, by Distribution channel (2021-2027) 7.4. Asia Pacific Glutethimide Market, by Country (2021-2027) • China • India • Japan • South Korea • Australia • ASIAN • Rest Of APAC 8. Middle East and Africa Glutethimide Market (2021-2027) 8.1. Middle East and Africa Glutethimide Market, by Type (2021-2027) 8.2. Middle East and Africa Glutethimide Market, by Application (2021-2027) 8.3. Middle East and Africa Glutethimide Market, by Distribution channel (2021-2027) 8.4. Middle East and Africa Glutethimide Market, by Country (2021-2027) • South Africa • GCC • Egypt • Nigeria • Rest Of ME&A 9. South America Glutethimide Market (2021-2027) 9.1. South America Glutethimide Market, by Type (2021-2027) 9.2. South America Glutethimide Market, by Application (2021-2027) 9.3. South America Glutethimide Market, by Distribution channel (2021-2027) 9.4. South America Glutethimide Market, by Country (2021-2027) • Brazil • Argentina • Rest Of South America 10. Company Profile: Key players 10.1. Pfizer Inc 10.1.1. Company Overview 10.1.2. Financial Overview 10.1.3. Global Presence 10.1.4. Capacity Portfolio 10.1.5. Business Strategy 10.1.6. Recent Developments 10.2. Pfizer Inc 10.3. Abbott Laboratories 10.4. Mankind Pharma 10.5. GSK PLC 10.6. Sanofi SA 10.7. Novartis 10.8. Agilent Technologies 10.9. Bristol Mayers Squibb 10.10. AstraZeneca 10.11. AbbVie Inc 10.12. Janssen Global Services 10.13. Johnson & Johnson 10.14. Astellas 10.15. Merck Sharp & Dohme Corp. 10.16. UCB SA 10.17. ALLERGAN